Swasthya Healthcare Private Limited
About Swasthya Healthcare Private Limited
Categories

-
IN
-
2022On CPHI since
-
100 - 249Employees
Company types
Primary activities
Meet us at
CPHI Frankfurt 2025
Messe Frankfurt
28 Oct 2025 - 30 Oct 2025
Products from Swasthya Healthcare Private Limited (13)
-
Product Amphotericin B Liposomal Injection 50mg
Description: Amphotericin B Liposomal is a broad-spectrum antifungal agent formulated in a liposomal delivery system to reduce toxicity and improve patient tolerability. It is used to treat severe systemic fungal infections and leishmaniasis, especially in immunocompromised patients.
Mechanis... -
Product Abiraterone Acetate Tablets USP 250 mg
Abiraterone Acetate Tablets USP 250 mg is a key androgen biosynthesis inhibitor used in the treatment of metastatic castration-resistant prostate cancer (mCRPC) and metastatic high-risk castration-sensitive prostate cancer (mCSPC).
Mechanism of Action (MOA): Abiraterone selectively inhibits CYP17, ... -
Product Enzalutamide Capsules 40 mg
nzalutamide Capsules 40 mg Description: Enzalutamide is a potent, orally administered androgen receptor inhibitor used in the treatment of prostate cancer. It blocks androgen receptor signaling pathways critical for the growth and survival of prostate cancer cells, thereby slowing disease progression. qq... -
Product Bendamustine Hydrochloride 100mg Powder for Parenteral use
Description :
Bendamustine hydrochloride (HCl) is a chemotherapeutic agent supplied as a sterile, lyophilized powder for injection. It is reconstituted and diluted before intravenous administration. Bendamustine is an alkylating agent with a unique structure combining a nitrogen mustard ... -
Product Deferasirox Tablets 250 mg
Description: Deferasirox is an oral iron-chelating agent used to reduce chronic iron overload in patients receiving long-term blood transfusions. It helps prevent organ damage caused by excess iron accumulation, particularly in conditions like thalassemia, sickle cell anemia, and other chronic anemias. qq... -
Product Enoxaparin Sodium Injection USP 40mg/0.4ml
Category: Anticoagulants
Enoxaparin Injection 40 mg, a low molecular weight heparin (LMWH), is widely used for the prevention and treatment of blood clots, ensuring patient safety and improved clinical outcomes.
Mechanism of Action (MOA): Enoxaparin enhances the activity of antithro... -
Product Fingolimod Capsules 0.5 mg
Description: Fingolimod is an oral immunomodulating agent used primarily in the treatment of Relapsing-Remitting Multiple Sclerosis (RRMS). It works by reducing the migration of lymphocytes into the central nervous system, thereby minimizing inflammatory damage to nerve cells.
Mechanism of Action: Fin... -
Product Iohexol Injection USP 300mg-50ml
Product Overview: Iohexol is widely used in computed tomography (CT) scans, angiography, and urography to improve image clarity, enabling precise diagnosis and treatment planning.
Key Features:
High-contrast enhancement for detailed imaging Excellent safety profile with l... -
Product Leuprolide Depot Injection 22.5 mg
Mechanism of Action (MOA): Leuprolide acts as a GnRH agonist, initially stimulating but eventually suppressing LH & FSH secretion, leading to decreased testosterone in men and estrogen in women.
Therapeutic UsProstate Cancer – Advanced and hormone-dependent cases
Endometriosis – Sympto... -
Product Nab-Paclitaxel Injection 100 mg/mL
DESCRIPTION: Nab-paclitaxel (nanoparticle albumin-bound paclitaxel) is a chemotherapy drug formulated as a sterile, preservative-free, injectable suspension. It contains paclitaxel bound to human albumin nanoparticles (130 nm), which improves its solubility and delivery to tumor tissues without ... -
Product Octreotide Injection 100 mcg/ml
Description : Octreotide is a synthetic long-acting somatostatin analog, used for the treatment of hormone-secreting tumors and other related conditions. It mimics natural somatostatin but has a longer half-life.
MOA: Octreotide mimics the action of somatostatin, a hormone that inhibits... -
Product Sorafenib Tablets 200 mg
Description :
Sorafenib is an oral anticancer medication available as 200 mg tablets. It is a multikinase inhibitor that targets tumor cell proliferation and angiogenesis.
Mechanism of Action:
Sorafenib inhibits multiple kinases involved in tumor growth and blood vessel ...
Swasthya Healthcare Private Limited Resources (1)
-
Whitepaper WHY are we exhibiting at CPHI?
Swasthya Healthcare & Sunbright Associated at CPHI Frankfurt 2025 – Let’s Connect!
We’re excited to be part of CPHI Frankfurt 2025, a key event for global pharma professionals. Here’s why you should meet us there:
Networking – Connect with industry leaders and decision-makers.Showcasing Our Expertise – Presenting our diverse portfolio, including Oncology, mAbs, Contrast Media ARVs and Nephrology.
Innovation – Showcasing our latest pharmaceutical solutions.
Partnerships – Exploring global collaborations for mutual growth.
Market Insights – Staying ahead with the latest industry trends.
Opportunities – Unlocking new business avenues in global healthcare.